• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Management of localized esophageal cancer in the older patient.老年患者局限性食管癌的管理
Oncologist. 2014 Apr;19(4):367-74. doi: 10.1634/theoncologist.2013-0178. Epub 2014 Mar 24.
2
Chemoradiation in elderly esophageal cancer patients: rationale and design of a phase I/II multicenter study (OSAGE).老年食管癌患者的放化疗:一项I/II期多中心研究(OSAGE)的原理与设计
BMC Cancer. 2017 Jul 13;17(1):483. doi: 10.1186/s12885-017-3465-4.
3
[Chemoradiotherapy and salvage surgery in a patient with advanced esophageal cancer].
Gan To Kagaku Ryoho. 2001 Aug;28(8):1145-8.
4
Chemoradiotherapy and radiotherapy alone in patients with esophageal cancer aged 80 years or older based on the Comprehensive Registry of Esophageal Cancer in Japan.基于日本食管癌综合登记数据库,对 80 岁及以上食管癌患者进行单纯放化疗与单纯放疗的比较。
Esophagus. 2020 Jul;17(3):223-229. doi: 10.1007/s10388-020-00725-w. Epub 2020 Feb 22.
5
Salvage esophagectomy after definitive chemoradiotherapy for esophageal cancer.
Dis Esophagus. 2007;20(4):301-4. doi: 10.1111/j.1442-2050.2007.00677.x.
6
Geriatric assessment and treatment outcomes in a Dutch cohort of older patients with potentially curable esophageal cancer.荷兰队列研究中,对可治愈的老年食管癌患者进行老年评估和治疗结局。
Acta Oncol. 2022 Apr;61(4):459-467. doi: 10.1080/0284186X.2022.2036366. Epub 2022 Feb 23.
7
Issues in the management of esophageal cancer and geriatric patients.食管癌与老年患者的管理问题
Chin Clin Oncol. 2017 Oct;6(5):51. doi: 10.21037/cco.2017.10.05.
8
Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma.食管鳞状细胞癌大剂量放化疗后的挽救性食管切除术
J Thorac Cardiovasc Surg. 2009 Jan;137(1):49-54. doi: 10.1016/j.jtcvs.2008.05.016.
9
New developments in the treatment of esophageal cancer.食管癌治疗的新进展。
Clin Adv Hematol Oncol. 2004 Feb;2(2):97-104.
10
Salvage surgery after failed chemoradiotherapy in squamous cell carcinoma of the esophagus.食管鳞状细胞癌放化疗失败后的挽救性手术
Eur J Surg Oncol. 2009 Mar;35(3):289-94. doi: 10.1016/j.ejso.2008.02.014. Epub 2008 Apr 8.

引用本文的文献

1
Definitive chemoradiotherapy in elderly patients with esophageal cancer: Safety and outcome.老年食管癌患者的根治性放化疗:安全性与疗效
Precis Radiat Oncol. 2023 Mar 25;7(1):51-58. doi: 10.1002/pro6.1190. eCollection 2023 Mar.
2
Induction Radiochemotherapy for Esophageal Cancer: Long-Term Outcomes from a Single-Center Study.食管癌的诱导放化疗:一项单中心研究的长期结果
J Clin Med. 2025 Jan 10;14(2):394. doi: 10.3390/jcm14020394.
3
Short- and Long-Term Outcomes in Elderly Patients with Resectable Esophageal Cancer: Upfront Esophagectomy Compared to Surgery after Neoadjuvant Treatments.可切除食管癌老年患者的短期和长期预后:与新辅助治疗后手术相比的 upfront 食管切除术
J Clin Med. 2024 Jul 22;13(14):4271. doi: 10.3390/jcm13144271.
4
Multicenter analysis on the value of standard (chemo)radiotherapy in elderly patients with locally advanced adenocarcinoma of the esophagus or gastroesophageal junction.多中心分析标准(化疗)放疗在老年局部晚期食管腺癌或食管胃交界腺癌患者中的价值。
Radiat Oncol. 2024 Mar 4;19(1):28. doi: 10.1186/s13014-024-02414-9.
5
Surgery versus radiotherapy for limited-stage small cell esophageal carcinoma: a multicenter, retrospective, cohort study in China (ChiSCEC).局限期小细胞食管癌手术与放疗的比较:中国多中心回顾性队列研究(ChiSCEC)。
Int J Surg. 2024 Feb 1;110(2):956-964. doi: 10.1097/JS9.0000000000000912.
6
Individualized treatment decision model for inoperable elderly esophageal squamous cell carcinoma based on multi-modal data fusion.基于多模态数据融合的不可手术老年食管鳞癌个体化治疗决策模型。
BMC Med Inform Decis Mak. 2023 Oct 23;23(1):237. doi: 10.1186/s12911-023-02339-5.
7
Developing sarcopenia during neoadjuvant therapy is associated with worse survival in esophageal adenocarcinoma patients.在新辅助治疗期间发生肌肉减少症与食管腺癌患者的生存预后更差相关。
Surgery. 2024 Mar;175(3):718-725. doi: 10.1016/j.surg.2023.09.017. Epub 2023 Oct 20.
8
Geriatric Radiation Oncology: What We Know and What Can We Do Better?老年肿瘤放射治疗学:我们了解多少,我们能做得更好?
Clin Interv Aging. 2023 May 4;18:689-711. doi: 10.2147/CIA.S365495. eCollection 2023.
9
Chemoradiotherapy in geriatric patients with squamous cell carcinoma of the esophagus: Multi-center analysis on the value of standard treatment in the elderly.老年食管鳞状细胞癌患者的放化疗:老年患者标准治疗价值的多中心分析
Front Oncol. 2023 Mar 3;13:1063670. doi: 10.3389/fonc.2023.1063670. eCollection 2023.
10
The Role of Age and Comorbidities in Esophagogastric Cancer Chemoradiation of the Frail Elderly (>70 Years): An Analysis from a Tertiary High Volume-Center.年龄和合并症在老年体弱(>70岁)食管癌和胃癌放化疗中的作用:来自大型三级中心的分析
Cancers (Basel). 2022 Dec 23;15(1):106. doi: 10.3390/cancers15010106.

本文引用的文献

1
Endoluminal high-dose-rate brachytherapy for early stage and recurrent esophageal cancer in medically inoperable patients.
Brachytherapy. 2013 Sep-Oct;12(5):463-70. doi: 10.1016/j.brachy.2012.12.001. Epub 2013 Feb 20.
2
Salvage esophagectomy after failed definitive chemoradiation for esophageal adenocarcinoma.根治性放化疗失败后的食管腺癌挽救性切除术。
Ann Thorac Surg. 2012 Oct;94(4):1126-32; discussion 1132-3. doi: 10.1016/j.athoracsur.2012.05.106. Epub 2012 Aug 24.
3
Preoperative chemoradiotherapy for esophageal or junctional cancer.术前放化疗治疗食管或食管胃交界癌。
N Engl J Med. 2012 May 31;366(22):2074-84. doi: 10.1056/NEJMoa1112088.
4
Adenocarcinoma of the esophagus and esophagogastric junction in patients older than 70 years: results of neoadjuvant radiochemotherapy followed by transthoracic esophagectomy.70 岁以上患者的食管和食管胃交界腺癌:新辅助放化疗后经胸食管切除术的结果。
J Visc Surg. 2012 Jun;149(3):e203-10. doi: 10.1016/j.jviscsurg.2012.03.006. Epub 2012 May 23.
5
Predictors of early death risk in older patients treated with first-line chemotherapy for cancer.一线化疗治疗癌症的老年患者早期死亡风险的预测因素。
J Clin Oncol. 2012 May 20;30(15):1829-34. doi: 10.1200/JCO.2011.35.7442. Epub 2012 Apr 16.
6
Geriatric surgery: past, present, and future.老年外科手术:过去、现在与未来。
Arch Surg. 2012 Jan;147(1):10. doi: 10.1001/archsurg.2011.1040.
7
Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study.预测老年癌症患者的化疗毒性:一项前瞻性多中心研究。
J Clin Oncol. 2011 Sep 1;29(25):3457-65. doi: 10.1200/JCO.2011.34.7625. Epub 2011 Aug 1.
8
Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia.肌肉减少症:老年人未被诊断的病症。当前共识定义:患病率、病因和后果。国际肌肉减少症工作组。
J Am Med Dir Assoc. 2011 May;12(4):249-56. doi: 10.1016/j.jamda.2011.01.003. Epub 2011 Mar 4.
9
Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial.可切除胃食管腺癌的围手术期化疗与单纯手术比较:FNCLCC 和 FFCD 多中心 III 期试验。
J Clin Oncol. 2011 May 1;29(13):1715-21. doi: 10.1200/JCO.2010.33.0597. Epub 2011 Mar 28.
10
Do elderly patients experience increased perioperative or postoperative morbidity or mortality when given neoadjuvant chemoradiation before esophagectomy?接受新辅助放化疗后行食管癌切除术的老年患者围手术期或术后发病率或死亡率是否增加?
Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1372-6. doi: 10.1016/j.ijrobp.2010.04.055. Epub 2010 Nov 23.

老年患者局限性食管癌的管理

Management of localized esophageal cancer in the older patient.

作者信息

Won Elizabeth, Ilson David H

机构信息

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

出版信息

Oncologist. 2014 Apr;19(4):367-74. doi: 10.1634/theoncologist.2013-0178. Epub 2014 Mar 24.

DOI:10.1634/theoncologist.2013-0178
PMID:24664485
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3983810/
Abstract

Most patients with gastroesophageal cancers are older than 65 years of age. The management of older patients poses challenges because they have multiple comorbidities and physiological changes associated with aging. Furthermore, data are limited on tolerance of cancer therapy and the use of combined-modality treatments in this patient population to guide their treatment. In this article, we focus on the management of older patients with localized esophageal cancer, highlighting the role of comprehensive geriatric assessment to identify and better tailor treatment approaches in this patient population. We review the literature and discuss the role of surgical resection and potential complications specific to an older patient. We review the rationale of combined-modality treatment and the potential benefits of a chemoradiotherapy-based approach in this patient population.

摘要

大多数食管癌和胃癌患者年龄在65岁以上。老年患者的治疗面临挑战,因为他们有多种合并症以及与衰老相关的生理变化。此外,关于该患者群体对癌症治疗的耐受性以及联合治疗方法的应用的数据有限,难以指导其治疗。在本文中,我们重点关注老年局限性食管癌患者的治疗,强调综合老年评估在识别和更好地定制该患者群体治疗方法方面的作用。我们回顾文献并讨论手术切除的作用以及老年患者特有的潜在并发症。我们还回顾了联合治疗的基本原理以及基于放化疗方法在该患者群体中的潜在益处。